Cedazuridine

Chemical Information
Myelodysplastic syndromes (MDS) are a group of hematopoietic neoplasms that give rise to variable cytopenias progressing to secondary acute myeloid leukemia (sAML), which is invariably fatal if untreated. Hypomethylating agents such as [decitabine] and [azacitidine] are used to treat MDS through inducing DNA hypomethylation and apoptosis of cancerous cells. Although effective, these compounds are rapidly metabolized by cytidine deaminase (CDA) prior to reaching systemic circulation when administered orally, necessitating intramuscular or intravenous administration routes. Cedazuridine is a fluorinated tetrahydrouridine derivative specifically designed to inhibit CDA and facilitate oral administration of hypomethylating agents. Cedazuridine was first reported in 2014, and was subsequently approved by the FDA on July 7, 2020, in combination with [decitabine] for sale by Astex Pharmaceuticals Inc under the name INQOVI®.
| CAS Number | 1141397-80-9 |
| PubChem CID | 25267009 |
| IUPAC Name | (4R)-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one |
| Molecular Formula | C9H14F2N2O5 |
| Molecular Weight | 268.21 |
| XLogP | -1.1 |
| Topological Polar Surface Area | 102 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 343 |
| Property | Value |
|---|---|
| Molecular Weight | 268.21 |
| XLogP3 | -1.1 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Exact Mass | 268.08707788 |
| Monoisotopic Mass | 268.08707788 |
| Topological Polar Surface Area | 102 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 343 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
Alternative Products
Popular Products

Superior Broth™
SKU: 0105|Size: 500 g

Recombinant Clostridium Perfringens recX Protein (aa 1-212) (strain SM101 / Type A)
SKU: VAng-Lsx00705-50gEcoli|Size: 50 µg (E. coli)

50G Dextran Sulfate
SKU: NAT1236|Size: 50 g

pMRNAxp mRNAExpress Vector
SKU: MR000PA-1|Size: 10 µg

Mouse anti Human CD22
SKU: CD22-GMS100H|Size: 100 Tests

180 kDa Plus Prestained Protein Marker
SKU: MP201-02|Size: 500 Reactions

180 kDa Plus Prestained Protein Marker
SKU: MP201-02|Size: 500 Reactions

8-Port Manifolds
SKU: 9621|Size: 10 Manifolds/Unit

NFKB1
SKU: MBS8535435-01|Size: 0.1 mL

5/16" Tubing
SKU: TUB-516|Size: 10 Feet (304.8 cm)

Recombinant Human Neuritin (NRN1), partial (Active)
SKU: CSB-AP002941HU-01|Size: 5 µg

Recombinant Human adenovirus F serotype 41 Hexon protein (L3), partial, Biotinylated
SKU: CSB-EP319334HIS-B-01|Size: 20 µg

Recombinant Human Syntenin-1 (SDCBP), partial
SKU: CSB-EP020893HU-01|Size: 20 µg

Recombinant Klebsiella pneumoniae Outer membrane protein assembly factor BamA (bamA), partial
SKU: CSB-EP473705KBH-01|Size: 20 µg

Recombinant Human Toll-like receptor 2 (TLR2), partial
SKU: CSB-EP023601HU1-01|Size: 20 µg

Recombinant Mouse Protein atonal homolog 1 (Atoh1)
SKU: CSB-EP002306MO-01|Size: 20 µg

Recombinant Mouse Protocadherin beta 7 (Pcdhb7), partial
SKU: CSB-EP5744MOb1-01|Size: 10 µg

Recombinant Mouse Enteropeptidase (Tmprss15), partial
SKU: CSB-MP018824MO-01|Size: 10 µg

Recombinant Mouse Max dimerization protein 1 (Mxd1)
SKU: CSB-BP015251MO-01|Size: 20 µg

Recombinant Human Tumor necrosis factor receptor superfamily member 5 (CD40), partial (Active)
SKU: CSB-AP005181HU-01|Size: 50 µg
